US 11384065
Heterocyclic compound as CSF-1R inhibitor and use thereof
granted A61KA61K31/4035A61K9/0019
Quick answer
US patent 11384065 (Heterocyclic compound as CSF-1R inhibitor and use thereof) held by Medshine Discovery Inc. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4035, A61K9/0019, A61K9/0053, A61P